期刊
CANCER CELL
卷 18, 期 1, 页码 9-10出版社
CELL PRESS
DOI: 10.1016/j.ccr.2010.06.010
关键词
-
资金
- NIAMS NIH HHS [R01 AR043369] Funding Source: Medline
A new clinical study reported in the New England Journal of Medicine unveils the long-awaited outcome of anti-CTLA-4 therapy for melanoma. It provides grounds for continued enthusiasm for cancer immunotherapy, deepens our thoughts on underlying mechanisms, and suggests exciting next steps.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
